KLAS Report Cites Alaris® System As Leader In Interoperability With EMRs

SAN DIEGO, June 9, 2015 /PRNewswire/ -- CareFusion, a BD company BDX, today announced its Alaris^® System intelligent infusion platform has been rated as the industry leader for interoperability with electronic medical records (EMRs) in the Smart Pump/EMR Integration report released today from KLAS.

The report from KLAS, an organization that independently monitors health care information technology performance through the active participation of thousands of health care organizations, says the Alaris System has the most organizations live with EMR interoperability solutions and cited CareFusion as leading in breadth of interoperability functionality.

"CareFusion has surpassed all other pump vendors to have the most organizations live with integration, having added seven since the last report," the KLAS report states. "They are also the only vendor live with syringe pump integration, and their customers are the most confident that pump integration is ready for widespread adoption."

The Alaris System can be wirelessly pre-populated with infusion order parameters directly from a hospital's EMR. Instead of manually programming the pump using the keypad, the pump is pre-populated with the patient's medication order after scanning the barcodes on the patient's ID band, on the medication to be administered and on the Alaris System smart infusion pump. Wirelessly programming the Alaris System with the patient's medication order from the verified physician order in the EMR helps ensure accurate IV medication administration and documentation, and reduces opportunities for human error.

With bi-directional communication, infusion data automatically flows back into the EMR, resulting in the programmed infusion order parameters being sent back into the patient's medical record in near real-time.¹ Automated IV medication administration documentation from the Alaris System to the EMR gives health care providers more timely and accurate infusion data to aid in clinical decision-making.

About CareFusion

CareFusion, a BD company, serves the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris^® infusion pumps and IV sets, MaxPlus^® and MaxZero^™ IV connectors and sets, Pyxis^® automated dispensing and patient identification systems, AVEA^®, LTV^® series and AirLife^® ventilation and respiratory products, ChloraPrep^® products, MedMined^® services for data mining surveillance, V. Mueller^® surgical instruments, and an extensive line of products that support interventional medicine. For more information please visit www.carefusion.com.

About BD
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visit www.bd.com.

¹Subject to Internet connection, device variability and selected settings.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/klas-report-cites-alaris-system-as-leader-in-interoperability-with-emrs-300096232.html

SOURCE CareFusion